_id
690daebbccc777a4e85d0aaf
Ticker
AMWL
Name
American Well Corp
Exchange
NYSE
Address
75 State Street, Boston, MA, United States, 02109
Country
USA
Sector
Healthcare
Industry
Health Information Services
Currency
USD
Website
https://business.amwell.com
Description
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as offers specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members. It also provides Carepoint devices, which transforms proprietary carts, peripherals, tablets, and TVs into digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Last Close
4.61
Volume
62964
Current Price
4.7
Change
1.9522776572668081
Last Updated
2025-11-28T12:13:34.861Z
Image
-
Ipo Date
2020-09-17T00:00:00.000Z
Market Cap
67285824
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9940000000000001
Sentiment Sources
3
Rating
3.2222
Target Price
8.125
Strong Buy
1
Buy
0
Hold
8
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
56286000
Cost Of Revenue
36222000
Gross Profit
20064000
Operating Expenses
46203000
Operating Income
-26139000
Interest Expense
638000
Pretax Income
-30694000
Net Income
-32378000
Eps
-1.9968286822996721
Dividends Per Share
-
Shares Outstanding
14723951
Income Tax Expense
1217000
EBITDA
-20976000
Operating Margin
-46.43961198166507
Total Other Income Expense Net
-4555000
Cash
200888000
Short Term Investments
-
Receivables
55578000
Inventories
1823000
Total Current Assets
271168000
Property Plant Equipment
5009000
Total Assets
359425000
Payables
5965000
Short Term Debt
3678000
Long Term Debt
-
Total Liabilities
92062000
Equity
254911000
Depreciation
9442000
Change In Working Capital
-3198000
Cash From Operations
-18766000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
299000
Net Change In Cash
-18184000
PE
-
PB
0.2989637234171927
ROE
-12.7016880401395
ROA
-9.008277109271754
FCF
-18766000
Fcf Percent
-0.33340439896244184
Piotroski FScore
1
Health Score
34
Deep Value Investing Score
6.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
3
Net Net Investing Score
8
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
56286000
Quarters > 0 > income Statement > cost Of Revenue
36222000
Quarters > 0 > income Statement > gross Profit
20064000
Quarters > 0 > income Statement > operating Expenses
46203000
Quarters > 0 > income Statement > operating Income
-26139000
Quarters > 0 > income Statement > interest Expense
638000
Quarters > 0 > income Statement > pretax Income
-30694000
Quarters > 0 > income Statement > net Income
-32378000
Quarters > 0 > income Statement > eps
-1.9968286822996721
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
16214711
Quarters > 0 > income Statement > income Tax Expense
1217000
Quarters > 0 > income Statement > EBITDA
-20976000
Quarters > 0 > income Statement > operating Margin
-46.43961198166507
Quarters > 0 > income Statement > total Other Income Expense Net
-4555000
Quarters > 0 > balance Sheet > cash
200888000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
55578000
Quarters > 0 > balance Sheet > inventories
1823000
Quarters > 0 > balance Sheet > total Current Assets
271168000
Quarters > 0 > balance Sheet > property Plant Equipment
5009000
Quarters > 0 > balance Sheet > total Assets
359425000
Quarters > 0 > balance Sheet > payables
5965000
Quarters > 0 > balance Sheet > short Term Debt
3678000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
92062000
Quarters > 0 > balance Sheet > equity
254911000
Quarters > 0 > cash Flow > net Income
-31911000
Quarters > 0 > cash Flow > depreciation
9442000
Quarters > 0 > cash Flow > change In Working Capital
-3198000
Quarters > 0 > cash Flow > cash From Operations
-18766000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
299000
Quarters > 0 > cash Flow > net Change In Cash
-18184000
Quarters > 0 > ratios > PE
-1.9968286822996721
Quarters > 0 > ratios > PB
0.2989637234171927
Quarters > 0 > ratios > ROE
-12.7016880401395
Quarters > 0 > ratios > ROA
-9.008277109271754
Quarters > 0 > ratios > FCF
-18766000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.33340439896244184
Quarters > 0 > health Score
34
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
70898000
Quarters > 1 > income Statement > cost Of Revenue
39367000
Quarters > 1 > income Statement > gross Profit
31531000
Quarters > 1 > income Statement > operating Expenses
49369000
Quarters > 1 > income Statement > operating Income
-17838000
Quarters > 1 > income Statement > interest Expense
845000
Quarters > 1 > income Statement > pretax Income
-20256000
Quarters > 1 > income Statement > net Income
-19696000
Quarters > 1 > income Statement > eps
-1.2392900760524936
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
15892970
Quarters > 1 > income Statement > income Tax Expense
-725000
Quarters > 1 > income Statement > EBITDA
-11058000
Quarters > 1 > income Statement > operating Margin
-25.160089142147875
Quarters > 1 > income Statement > total Other Income Expense Net
-2418000
Quarters > 1 > balance Sheet > cash
219072000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
53557000
Quarters > 1 > balance Sheet > inventories
2184000
Quarters > 1 > balance Sheet > total Current Assets
289653000
Quarters > 1 > balance Sheet > property Plant Equipment
5880000
Quarters > 1 > balance Sheet > total Assets
388656000
Quarters > 1 > balance Sheet > payables
3728000
Quarters > 1 > balance Sheet > short Term Debt
3701000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
94083000
Quarters > 1 > balance Sheet > equity
282588000
Quarters > 1 > cash Flow > net Income
-19531000
Quarters > 1 > cash Flow > depreciation
8224000
Quarters > 1 > cash Flow > change In Working Capital
-1758000
Quarters > 1 > cash Flow > cash From Operations
-4724000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-1000
Quarters > 1 > cash Flow > net Change In Cash
-3339000
Quarters > 1 > ratios > PE
-1.2392900760524936
Quarters > 1 > ratios > PB
0.26433167367333366
Quarters > 1 > ratios > ROE
-6.96986425467465
Quarters > 1 > ratios > ROA
-5.067720554938043
Quarters > 1 > ratios > FCF
-4724000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.06663093458207565
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
66833000
Quarters > 2 > income Statement > cost Of Revenue
39374000
Quarters > 2 > income Statement > gross Profit
27459000
Quarters > 2 > income Statement > operating Expenses
54405000
Quarters > 2 > income Statement > operating Income
-26946000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-17788000
Quarters > 2 > income Statement > net Income
-18704000
Quarters > 2 > income Statement > eps
-1.1934660541092394
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
15672000
Quarters > 2 > income Statement > income Tax Expense
568000
Quarters > 2 > income Statement > EBITDA
-8991000
Quarters > 2 > income Statement > operating Margin
-40.31840557808268
Quarters > 2 > income Statement > total Other Income Expense Net
9158000
Quarters > 2 > balance Sheet > cash
222411000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
72004000
Quarters > 2 > balance Sheet > inventories
2530000
Quarters > 2 > balance Sheet > total Current Assets
311500000
Quarters > 2 > balance Sheet > property Plant Equipment
6722000
Quarters > 2 > balance Sheet > total Assets
419468000
Quarters > 2 > balance Sheet > payables
6432000
Quarters > 2 > balance Sheet > short Term Debt
3723000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
113694000
Quarters > 2 > balance Sheet > equity
293954000
Quarters > 2 > cash Flow > net Income
-18356000
Quarters > 2 > cash Flow > depreciation
7801000
Quarters > 2 > cash Flow > change In Working Capital
-12734000
Quarters > 2 > cash Flow > cash From Operations
-25108000
Quarters > 2 > cash Flow > capital Expenditures
9000
Quarters > 2 > cash Flow > cash From Investing
19391000
Quarters > 2 > cash Flow > cash From Financing
543000
Quarters > 2 > cash Flow > net Change In Cash
-5905000
Quarters > 2 > ratios > PE
-1.1934660541092394
Quarters > 2 > ratios > PB
0.2505779815889561
Quarters > 2 > ratios > ROE
-6.362900317736789
Quarters > 2 > ratios > ROA
-4.45898137641012
Quarters > 2 > ratios > FCF
-25117000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-0.37581733574731047
Quarters > 2 > health Score
33
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
71006000
Quarters > 3 > income Statement > cost Of Revenue
44821000
Quarters > 3 > income Statement > gross Profit
26185000
Quarters > 3 > income Statement > operating Expenses
64870000
Quarters > 3 > income Statement > operating Income
-38685000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-43041000
Quarters > 3 > income Statement > net Income
-42654000
Quarters > 3 > income Statement > eps
-2.7696447609501256
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
15400531
Quarters > 3 > income Statement > income Tax Expense
1528000
Quarters > 3 > income Statement > EBITDA
-33941000
Quarters > 3 > income Statement > operating Margin
-54.481311438469994
Quarters > 3 > income Statement > total Other Income Expense Net
-4356000
Quarters > 3 > balance Sheet > cash
228316000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
71885000
Quarters > 3 > balance Sheet > inventories
2858000
Quarters > 3 > balance Sheet > total Current Assets
316993000
Quarters > 3 > balance Sheet > property Plant Equipment
7579000
Quarters > 3 > balance Sheet > total Assets
435968000
Quarters > 3 > balance Sheet > payables
5015000
Quarters > 3 > balance Sheet > short Term Debt
3690000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
119724000
Quarters > 3 > balance Sheet > equity
304772000
Quarters > 3 > cash Flow > net Income
-42654000
Quarters > 3 > cash Flow > depreciation
8208000
Quarters > 3 > cash Flow > change In Working Capital
2626000
Quarters > 3 > cash Flow > cash From Operations
-13435000
Quarters > 3 > cash Flow > capital Expenditures
2416000
Quarters > 3 > cash Flow > cash From Investing
-4131000
Quarters > 3 > cash Flow > cash From Financing
-2000
Quarters > 3 > cash Flow > net Change In Cash
-16331000
Quarters > 3 > ratios > PE
-2.7696447609501256
Quarters > 3 > ratios > PB
0.23749719692097698
Quarters > 3 > ratios > ROE
-13.99538015303243
Quarters > 3 > ratios > ROA
-9.783745596007046
Quarters > 3 > ratios > FCF
-15851000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.2232346562262344
Quarters > 3 > health Score
34
Valuation > metrics > PE
-1.9968286822996721
Valuation > metrics > PB
0.2989637234171927
Valuation > final Score
70
Valuation > verdict
70.1% Undervalued
Profitability > metrics > ROE
-12.7016880401395
Profitability > metrics > ROA
-11.940199433561482
Profitability > metrics > Net Margin
-0.5752407348186049
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.36115350063355445
Risk > metrics > Interest Coverage
-40.970219435736674
Risk > final Score
-104
Risk > verdict
High
Liquidity > metrics > Current Ratio
28.120709322824847
Liquidity > metrics > Quick Ratio
27.931660271699677
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-24
Prev Risks > 1
48
Prev Risks > 2
43
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-16T22:23:40.724Z
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as offers specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members. It also provides Carepoint devices, which transforms proprietary carts, peripherals, tablets, and TVs into digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ACan AMWL stock deliver strong annual returns - July 2025 Opening Moves & Weekly High Return Opportunities Улправда
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$8.125
Analyst Picks
Strong Buy
1
Buy
0
Hold
8
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 33.41% of the total shares of American Well Corp
1.
RIMA MANAGEMENT, LLC(8.1281%)
since
2025/06/30
2.
Morgan Stanley - Brokerage Accounts(7.6579%)
since
2025/06/30
3.
Caledonia (Private) Investments Pty Ltd(5.0071%)
since
2025/06/30
4.
Vanguard Group Inc(3.9271%)
since
2025/06/30
5.
BlackRock Inc(1.5149%)
since
2025/06/30
6.
Renaissance Technologies Corp(1.0861%)
since
2025/06/30
7.
Rock Point Advisors, LLC(1.0747%)
since
2025/06/30
8.
Geode Capital Management, LLC(0.9135%)
since
2025/06/30
9.
Millennium Management LLC(0.6972%)
since
2025/06/30
10.
Bridgeway Capital Management, LLC(0.5989%)
since
2025/06/30
11.
Takeda Pharmaceutical Co Ltd(0.4813%)
since
2025/06/30
12.
Dimensional Fund Advisors, Inc.(0.4432%)
since
2025/06/30
13.
State Street Corp(0.3003%)
since
2025/06/30
14.
Susquehanna International Group, LLP(0.2532%)
since
2025/06/30
15.
Squarepoint Ops LLC(0.253%)
since
2025/06/30
16.
Two Sigma Investments LLC(0.2339%)
since
2025/06/30
17.
HighTower Advisors, LLC(0.232%)
since
2025/06/30
18.
Two Sigma Advisers, LLC(0.2182%)
since
2025/06/30
19.
Citadel Advisors Llc(0.201%)
since
2025/06/30
20.
Jane Street Group LLC(0.1896%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.